Inventia Life Sciences

Founded: 2013
Founders: Julio Ribeiro, Aidan O'Mahony, Cameron Ferris, Peter Arthur

Inventia Life Sciences makes RASTRUM, a 3D bioprinting platform that produces 3D cell models for research. Scientists use these models in cancer and drug discovery work. The platform also offers a synthetic alternative to Matrigel, a material commonly used to grow cells.

Why it matters in Australia: Blackbird, an Australian fund, has backed Inventia since an early round in 2017, and the company's website is an Australian .com.au domain.

Backed by

Blackbird first invested 2017 · Early Blackbird profile ↗

Similar companies

Accretion Bio To cure disease, you first have to see it. We watch single molecules move inside living neurons in real time - revealing how brain disease begins, and how to stop it. Antler Australia Andromeda Where technology meets empathy – pioneering the future of human-robot interaction. Main Sequence Everlab Marc, Sam, Anshul and Steven are on a mission to help people live longer, healthier lives. AirTree 9 roles in Australia Auggie Auggie is the AI patient retention platform that turns dormant dental patient lists into recovered revenue. Antler Australia Currus Biologics Developing the next generation of CAR-T cell therapies to treat solid cancers. Main Sequence indi One connected system for child development care Antler Australia

The summary above was written with AI from the company's own site and its backers' listings, and checked by an editor. Backers, years and rounds are as each fund lists them. Founded year, head office, founders and offices are as its website state them. Open roles are read daily from the funds' jobs boards.